Background The use of glycated albumin (GA) has been proposed as an additional glycemic control marker particularly useful in intermediate-term monitoring and in situation when HbA1c test is not reliable. Methods We have performed the first multicenter evaluation of the analytical performance of the enzymatic method quantILab Glycated Albumin assay implemented on the most widely used clinical chemistry analyzers (i.e. Abbott Architect C8000, Beckman Coulter AU 480 and 680, Roche Cobas C6000, Siemens ADVIA 2400 and 2400 XPT). Results The repeatability of the GA measurement (expressed as CV, %) implemented in the participating centers ranged between 0.9% and 1.2%. The within-laboratory CVs ranged between 1.2% and 1.6%. A good alignment between laboratories was found, with correlation coefficients from 0.996 to 0.998. Linearity was confirmed in the range from 7.6 to 84.7%. Conclusion The new enzymatic method for glycated albumin evaluated by our investigation is suitable for clinical use.
Multicenter evaluation of an enzymatic method for glycated albumin / R. Paleari, G. Bonetti, C. Callà, M. Carta, F. Ceriotti, N. Di Gaetano, M. Ferri, E. Guerra, G. Lavalle, C.L. Cascio, F.G. Martino, M. Montagnana, M. Moretti, G. Santini, D. Scribano, R. Testa, A. Vero, A. Mosca. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - 469(2017), pp. 81-86.
Multicenter evaluation of an enzymatic method for glycated albumin
R. PaleariPrimo
;A. Mosca
2017
Abstract
Background The use of glycated albumin (GA) has been proposed as an additional glycemic control marker particularly useful in intermediate-term monitoring and in situation when HbA1c test is not reliable. Methods We have performed the first multicenter evaluation of the analytical performance of the enzymatic method quantILab Glycated Albumin assay implemented on the most widely used clinical chemistry analyzers (i.e. Abbott Architect C8000, Beckman Coulter AU 480 and 680, Roche Cobas C6000, Siemens ADVIA 2400 and 2400 XPT). Results The repeatability of the GA measurement (expressed as CV, %) implemented in the participating centers ranged between 0.9% and 1.2%. The within-laboratory CVs ranged between 1.2% and 1.6%. A good alignment between laboratories was found, with correlation coefficients from 0.996 to 0.998. Linearity was confirmed in the range from 7.6 to 84.7%. Conclusion The new enzymatic method for glycated albumin evaluated by our investigation is suitable for clinical use.File | Dimensione | Formato | |
---|---|---|---|
2017_Glycated albumin CCA.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
626.61 kB
Formato
Adobe PDF
|
626.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.